A Single Institution's Experience with Cytogenetic and MRD Outcomes in Pediatric Acute Lymphoblastic Leukemia
Author(s) -
Asim Amjad,
Rabia Wali,
Sadia Anjum,
Raheela Mansoor
Publication year - 2019
Publication title -
journal of college of physicians and surgeons pakistan
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.229
H-Index - 33
eISSN - 1681-7168
pISSN - 1022-386X
DOI - 10.29271/jcpsp.2019.06.549
Subject(s) - medicine , regimen , minimal residual disease , lymphoblastic leukemia , pediatrics , leukemia , cancer
To determine the frequency of cytogenetic type and its significance in the prognostic outcome of the pediatric patients in acute lymphoblastic leukemia (ALL), aged 1 to 15 years, and also determine the importance of minimal residual disease (MRD) in the management of the condition.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom